Photochemical mutagenesis: examples and toxicological relevance

Area of Science:

• Photochemistry
• Toxicology
• Molecular Biology

Background:

• Ultraviolet (UV) light exposure is a primary cause of DNA damage and skin cancer.
• Certain chemicals and pharmaceuticals can absorb light, leading to indirect DNA damage through photogenotoxicity.
• Previous studies identified photomutagenic properties in psoralen, chlorpromazine derivatives, and fluoroquinolone antibiotics.

Purpose of the Study:

• To investigate the photogenotoxic potential of pharmaceutical compounds.
• To understand the mechanisms of light-induced DNA damage by exogenous agents.
• To assess the implications of photogenotoxicity in drug development and sunscreen formulations.

Main Methods:

• Genotoxicity assays, including the Ames test (strain TA102), were used to evaluate photomutagenic activity.
• Mammalian cell tests for gene mutations and chromosomal aberrations were conducted.
• Mechanisms involving reactive oxygen species (ROS) and direct photochemical reactions were considered.

Main Results:

• A novel anxiolytic agent (Ro 19-8022) exhibited significant photomutagenic and photogenotoxic activity.
• A bisquinoline derivative (Ro 47-7737) also demonstrated photogenotoxic properties.
• Both compounds' development was terminated due to observed photogenotoxicity.

Conclusions:

• Photogenotoxicity is a critical factor in pharmaceutical development, necessitating careful risk-benefit assessment.
• Sunscreen ingredients, while UV absorbers, may pose risks if they photodegrade into reactive molecules.
• Understanding photochemical mutagenesis is crucial for both drug safety and sunscreen efficacy.